Minster Pharmaceuticals Plc - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Minster Pharmaceuticals Plc Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Minster Pharmaceuticals Plc. The Group's principal activity is developing and selling drugs specialising in compounds for the treatment of neurological and psychiatric conditions. Products include Tonabersat and Sabcomeline. Tonabersat are neuronal gap junction blockers, which have significant potential in the prevention of migraine and probably also in other neurological indications. Sabcomeline, a muscarinic receptor partial agonist, has potential in the treatment of chronic schizophrenia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report